Perth drug researcher Phylogica has received Notice of Allowance for a pending patent application covering a high level screening method for isolating Phylomer® and other drug candidates that block disease-related protein interactions.

Perth drug researcher Phylogica has received Notice of Allowance for a pending patent application covering a high level screening method for isolating Phylomer® and other drug candidates that block disease-related protein interactions.